Compare HCA Health Inc (HCA) vs Centrus Energy Corp (LEU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Centrus Energy Corp — how do they compare? HCA Health Inc trades at $443.69 (market cap $96.35B), while Centrus Energy Corp trades at $144.89 (market cap $2.91B). The key difference: HCA Health Inc is far larger — about 33.1× Centrus Energy Corp's market cap, and HCA Health Inc pays a 0.7% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Centrus Energy Corp for 29 Days on average.
| HCA | LEU | |
|---|---|---|
Market Cap | $96.35B | $2.91B |
Volume | 1,079,453 | 903,777 |
Sector | Health | Energy |
52-Week High | $545.13 | $436.00 |
52-Week Low | $361.32 | $138.18 |
Typical Hold Time | 76 Days | 29 Days |
Enterprise Value | $146.88B | $2.22B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.
The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.
Centrus Energy (LEU) trades at $147.14, down 4.38% on the day, with a neutral technical signal. The company reported Q2 2026 EPS of $0.77, beating estimates, but faces declining profitability margins into 2026. Recent news highlights its strategic position as a supplier of High-Assay Low-Enriched Uranium (HALEU), benefiting from U.S. nuclear energy growth and partnerships, though execution risks remain high.
Outlook is mixed: strong analyst consensus price target of $218.10 implies significant upside, supported by nuclear sector tailwinds and new contracts. However, high valuation multiples (P/E 77.85), volatile cash flows, and margin compression pose risks. Investors should weigh growth potential against execution challenges in a capital-intensive industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →
